Know Which COVID-19 Rxs May Be Too Soon for Prime Time

April 2021

We're getting questions about using inhaled steroids, colchicine, or fluvoxamine to treat outpatients with COVID-19.

Inhaled steroids (budesonide, etc) and oral colchicine are getting buzz for their anti-inflammatory effects...and the antidepressant fluvoxamine (Luvox) may help regulate the immune response.

But for now, DON'T expect your pharmacist to recommend any of these meds to treat COVID-19. There's not much evidence...and some studies aren't "peer-reviewed" by experts or published yet.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Dispensing Don't Leave Off Key Details in Rx Sigs
COVID-19 Listen for New Questions About COVID-19 Vaccines
COVID-19 Know Which COVID-19 Rxs May Be Too Soon for Prime Time
HIV & AIDS Understand the New INSTI HIV Self Test for Use at Home
Headache Help Aimovig Patients Get Set Up With a Blood Pressure Monitor
Bowel Preps Avoid Mix-Ups With Bowel Preps
Diabetes Stay Alert for Patients With Diabetes Who May Need a Statin
Respiratory & Allergy Watch for Jorveza, a New Med for Eosinophilic Esophagitis
Immunosuppressives Be Aware of New Safety Issues With Xeljanz

Know Which COVID-19 Rxs May Be Too Soon for Prime Time

Practical advice for a better career, with unlimited access to CE

Table of Contents